Senior Scientist I, Cancer Genomics, Clinical Biomarker Development

Role: Senior Scientist in Cancer Genomics within Clinical Biomarker Development, focused on applying advanced genomics and multi-omics analyses to inform RAS(ON) inhibitor clinical programs across Phase I-III trials. Responsibilities: analyze clinical biomarker data, integrate multi-omics datasets to explore disease biology, resistance mechanisms, and drug response; collaborate across cross-functional teams and communicate findings to diverse audiences. Requirements: Ph.D. in Cancer Genomics, Bioinformatics, or related field; 2-8 years post-PhD experience analyzing cancer genomics data, including ctDNA and tumor tissue sequencing; proficiency in R/Python, command line, and cloud/HPC environments; strong foundation in cancer biology, particularly RAS/MAPK pathways in pancreatic, lung, or colorectal cancers. Preferred: experience with clinical endpoints, RWE analytics, longitudinal ctDNA analysis, and deep expertise in relevant cancer types. High-Value: Oncology, RAS pathway, liquid biopsy, NGS data analysis, clinical biomarker development, early-phase clinical trials, cross-functional collaboration. WorkSetup: Location details not specified; salary range noted for Redwood City, CA.